Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
J Biomol Screen. 2011 Jun;16(5):467-75. doi: 10.1177/1087057111402200. Epub 2011 May 4.
J Biomol Screen. 2011.
PMID: 21543640